Biosimilars Market to 2025 – Pfizer, Biocon, Samsung BioLogics, Mylan N.V, Amgen

(EMAILWIRE.COM, July 21, 2018 ) A biosimilar is a biological product which is similar to an FDA approved biologic product of another manufacturer. Owing to the complexities associated with development & manufacture of biosimilar products, these are manufactured by companies with highly skillful workforce...